Created in 1996, the ARUP Institute for Clinical and Experimental Pathology® seeks to expand the quantity, quality, and utility of laboratory medicine. Since its inception, the institute has developed approximately 620 tests that ARUP now performs in-house. Of these 620 tests, 335 were developed by institute scientists, while 285 others were improved and validated so that ARUP could perform them in-house rather than continue to refer them out. Moreover, ARUP research scientists have shared their knowledge, experience, and new developments with the scientific community by publishing more than 1,200 original peer-reviewed research publications in leading journals.
The institute’s mission is to be at the forefront of innovative research and development in clinical and experimental
laboratory medicine and to continually contribute to the profession.
The institute's focus covers the spectrum of medical laboratory medicine:
Executive Director
|
Project CategoriesThe ARUP Institute for Clinical and Experimental Pathology® sponsors projects within four broad categories: creating new laboratory tests; improving current clinical laboratory tests; evaluating and critiquing tests, including alpha- and beta-site protocols; and conducting basic and clinical research projects. Research performed on human subjects is conducted under informed consent following the protocols approved by the University of Utah Institutional Review Board (IRB).
|
Hymas WC, et al. Development of a multiplex real-time RT-PCR assay for detection of influenza A, influenza B, RSV and typing of the 2009-H1N1 influenza virus. J Virol Methods 2010;167(2):113–18.
Slev PR, et al. Pediatric reference intervals for random urine calcium, phosphorus and total protein. Pediatr Nephrol 2010;25(9):1707–10.
Slattery ML, et al. Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control 2010;21(8):1237–45.
La'ulu SL, Roberts WL. Performance characteristics of five cardiac troponin I assays. Clin Chim Acta 2010;411(15–16):1095–101.
Owen WE, Rawlins ML, Roberts WL. Selected performance characteristics of the Roche Elecsys® testosterone II assay on the Modular analytics E 170 analyzer. Clin Chim Acta 2010;411(15–16):1073–9.
Crockett DK, et al. The Alport syndrome COL4A5 variant database. Hum Mutat 2010;31(8):E1652–7.
Simonson TS, et al. Genetic evidence for high-altitude adaptation in Tibet. Science 2010;329(5987):72–5.